Eli Lilly Stock Considered for Split Amid Obesity Drug Rally

Eli Lilly & Co.'s stock, consistently trading above $1,000 per share due to the success of its obesity drugs, is now seen by some analysts as a prime candidate for a stock split.

4 Aug, 11:00 — 4 Aug, 11:00

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh21d ago

Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally

Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.

By Angel Adegbesan

Read full article →

PERSPECTA

PERSPECTA

Eli Lilly Stock Considered for Split Amid Obesity Drug Rally

Sources

Eli Lilly Ripe for Stock Split After Obesity Drug-Fueled Rally

Related Stories

Schwab SCHD ETF Sees Significant Inflow Amidst Climb

Canada Imposes Retaliatory Tariffs on US Goods Amid Trade Dispute

Should Borrowers Switch from Floating to Fixed Home Loans Now?

Nvidia Earnings Report Anticipated Amidst Stock Volatility

PERSPECTA